Latest hepatocellular carcinoma News

Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
Targeting Stem Cell Signaling Could Halt Liver Cancer Progression Elucidating novel therapeutic target
New Curtin-led research aims to reduce stillbirth among Aboriginal families
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
International experts develop Clinical Care Pathway in response to NASH epidemic
New funding to support innovative medical research
New medicines for Australians with multiple sclerosis, lymphoma, carcinoma and reproductive cancers
New medicines for Australians with multiple sclerosis, lymphoma, carcinoma and reproductive cancers
Even mild fatty liver disease is linked to increased mortality
Investment in liver cancer medicines matched with prevention are changing Australian lives
Budget 2020-21: Record health and aged care investment under Australia’s COVID-19 pandemic plan
Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease
Laser-welded sugar: Sweet way to 3D-print blood vessels
New AGA guidance addresses cancer screening in NAFLD patients
More than $47 million awarded to Monash University for vital medical research
Low-dose aspirin linked to reduced liver cancer risk